1.) Kochi researchers target residual glioma cancer cells - for this photodyanamic therapy is used -- Glioma is brain cancer -- even after destruction of cencer cells their residual cells remain and this might give a chance for their re-occurance of cancer -- so now they target these residual cells also using some nanoparticles encapsulating the drug.
Quer criar suas próprias Notas gratuitas com a GoConqr? Saiba mais.